Medicina Webinar | Multimodal Approaches in Oligometastatic Genitourinary Cancer: What’s the Optimal Balance?
the chair
8th Medicina Webinar
Multimodal Approaches in Oligometastatic Genitourinary Cancer: What’s the Optimal Balance?
The concept of oligometastatic disease has transformed the therapeutic landscape of genitourinary cancers, offering new opportunities for durable control and even cures in selected patients. As our understanding of tumor biology deepens and imaging becomes more sensitive, the boundaries between localized and metastatic disease continue to blur. This webinar, “Multimodal Approaches in Oligometastatic Genitourinary Cancer: What’s the Optimal Balance?”, will explore how to integrate systemic and local treatments—surgery, radiotherapy, and novel systemic agents—in a patient-centered, evidence-based manner. Through expert discussion and clinical insights, we’ll address how to define optimal patient selection, timing, and treatment sequencing to achieve the best oncological and quality-of-life outcomes.
Date: 25 November 2025
Time: 3:30 pm CET | 9:30 am EST
Webinar ID: 825 1539 8301
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chair
Meet Our Speakers
Dr. Natalia Vidal
Department of Medical Oncology, Hospital Clínico San Carlos de Madrid, Madrid, Spain;
Dr. Natalia Vidal is a medical oncologist specializing in genitourinary tumors at the Hospital Clínico San Carlos. Subinvestigator on more than 30 clinical trials and 20 observational studies.
Dr. Noelia Sanmamed Salgado
Hospital Clínico San Carlos de Madrid, Madrid, Spain;
Dr. Sanmamed Salgado is currently a radiation oncologist at Clinico San Carlos Hospital (Madrid) focused on genitourinary and gynecologic malignancies using VMAT, stereotactic radiotherapy, and brachytherapy approaches.
She completed her Medical Degree at Santiago de Compostela University and her Radiation Oncology specialty training in Valladolid, including 3 months at the MD Anderson Cancer Center and University of Pennsylvania Hospital in the USA.
In 2017, she moved to Toronto for 2 years with the goal of improving her clinical and research skills, particularly in regard to brachytherapy, as a clinical research fellow at the Radiation Medicine Program, Princess Margaret Cancer. During this period, she obtained an Abbvie CARO Uro-Oncologic Radiation Award and an ABS Resident Grant Award. Dr. Sanmamed presented her PhD in March 2023.
She is an active member in the European (ESTRO), Spanish (SEOR), and American (ASTRO) societies of radiation oncology, as well as the American Brachytherapy Society. She has co-authored publications in European Urology, BJU, Brachytherapy, and the main journals of her specialty: Radiotherapy & Oncology and IJROBP.
Dr. Riccardo Campi
Consultant Urologist, Unit of Urology and Renal Transplantation Oncology Department, Careggi University Hospital;
Dr. Riccardo Campi, MD, PhD, FEBU, is a consultant urologist at the Unit of Urologic Robotic, Minimally Invasive Surgery and Renal Transplantation of Careggi University Hospital in Florence, Italy, one of the highest-volume tertiary referral cancer Centres in Italy. Dr. Campi is an active member of several national and international societies. He is a member and past Chairman (2021-2025) of the European Association of Urology EAU Young Academic Urologists YAU Renal Cancer working group and an Associate Member of the EAU Guidelines Panel on Renal Cell Carcinoma. He is also an Associate Member of the EAU Section of Oncological Urology ESOU and a Member of the Italian Society of Urology SIU Research Office. Dr. Campi is an Associate Editor of European Urology Oncology.
He has authored numerous editorials and book chapters and over 350 publications in peer-reviewed journals. He serves as a reviewer and editorial board member for high-ranked journals in the field of urology. Dr. Campi has an active research portfolio in the field of urologic oncology and is actively involved in several large studies including international trials in urologic oncology. His main clinical and academic interests are renal cancer, with a special emphasis on both the diagnosis and management of localized renal masses, renal transplantation, and minimally invasive surgery.
ORCID ID: http://orcid.org/0000-0001-5237-0888.
